tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Martin Fan, 29 are a BUY (78.38%), 8 are a HOLD (21.62%).
Analyst Martin Fan, currently employed at WEDBUSH, carries an average stock price target met ratio of 37.83% that have a potential upside of 25.48% achieved within 29 days.
Martin Fan’s has documented 74 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ORKA, Oruka Therapeutics at 24-Sep-2026.
Analyst best performing recommendations are on NKTR (NEKTAR THERAPEUTICS).
The best stock recommendation documented was for NKTR (NEKTAR THERAPEUTICS) at 4/21/2026. The price target of $95 was fulfilled within 1 day with a profit of $3.16 (3.22%) receiving and performance score of 32.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Aug-2024
$60
$14.05 (30.58%)
13 days ago
(30-Sep-2026)
11/13 (84.62%)
$9.74 (19.38%)
385
Buy Since 10-Jun-2026
$95
$49.05 (106.75%)
$95
19 days ago
(24-Sep-2026)
0/3 (0%)
$43.3 (83.75%)
Buy Since 03-Oct-2024
$81
$35.05 (76.28%)
$85
20 days ago
(23-Sep-2026)
3/5 (60%)
$30.23 (59.54%)
135
Buy Since 17-Mar-2026
$76
$30.05 (65.40%)
$60
5 months ago
(13-May-2026)
3/4 (75%)
$13.31 (21.23%)
47
Buy Since 16-Feb-2024
$93
$29.85 (47.27%)
$95
5 months 9 days ago
(04-May-2026)
0/6 (0%)
$23.22 (33.28%)
Which stock is Martin Fan most bullish on?
Which stock is Martin Fan most reserved on?
What Year was the first public recommendation made by Martin Fan?
